Craft

OrthoPediatrics

Stock Price

$27.5

2024-04-05

Market Capitalization

$646.9 M

2024-04-05

Revenue

$148.7 M

FY, 2023

OrthoPediatrics Summary

Company Summary

Overview
OthoPediatrics is a bioscience company dedicated to improving the resources available for treating children's orthopedic conditions through inventing, designing, and distributing innovative and anatomically appropriate implants, unique instrumentation and biologics for pediatric and small stature patients. The QCR by OrthoPediatrics is a game changing, disruptive technology. With an operating sound level just above a whisper and no vibration, the OrthoPediatrics QCR completely removes anxiety due to the noise and vibration.
Type
Public
Status
Active
Founded
2006
HQ
Warsaw, IN, US | view all locations
Website
http://www.orthopediatrics.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Bryan Hughes

    Bryan Hughes, Director

    • Marie Infante

      Marie Infante, Director

      • Fred Hite

        Fred Hite, Chief Financial Officer, Director

        • Mark Throdahl

          Mark Throdahl, President & Chief Executive Officer, Director

        Operating MetricsView all

        Patients

        16K

        Y, 2016

        Distributors

        31

        Nov, 2017

        Patents Issued

        21

        Nov, 2017

        LocationsView all

        1 location detected

        • Warsaw, IN HQ

          United States

          2850 Frontier Dr

        OrthoPediatrics Financials

        Summary Financials

        Revenue (FY, 2023)
        $148.7M
        Gross profit (FY, 2023)
        $111.3M
        Net income (FY, 2023)
        ($21.0M)
        Cash (FY, 2023)
        $31.1M
        EBIT (FY, 2023)
        ($26.8M)

        Footer menu